10-year survival of a patient with metastatic prostate cancer: Case report and literature review

Submitted: September 29, 2015
Accepted: September 29, 2015
Published: September 30, 2015
Abstract Views: 3068
PDF: 1153
SUPPLEMENTARY MATERIAL: 339
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages combined is 98.8%. Patients diagnosed with metastatic prostate cancer have median survival from 2 to 3 years. We describe a case of 64-year old man who clinically presented with inguinal lymphadenopathy. Because of elevated PSA levels biopsy of prostate was done and adenocarcinoma was diagnosed. Biopsy of inguinal lymph nodes confirmed the diagnosis of prostate cancer. Hormonal treatment was started and at the most recent follow-up, 10 years later, the patient is asymptomatic with no clinical signs of disseminated disease.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Krpina, K., Markić, D., Rahelić, D., Ahel, J., Rubinić, N., & Španjol, J. (2015). 10-year survival of a patient with metastatic prostate cancer: Case report and literature review. Archivio Italiano Di Urologia E Andrologia, 87(3), 252–253. https://doi.org/10.4081/aiua.2015.3.252